ASGCT
@ASGCTherapy
Advancing knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease.
Want to connect with FDA and ARPA-H leaders about gene therapy policy? ASGCT's Policy Summit features Denise Gavin, Mimi Lee, and John Schiel in panel discussions with extended Q&A. Register for exclusive access. bit.ly/4o4es9k #ASGCTadvocacy
#MTO call for papers! Submit your work by Sept. 30 for #MolecularTherapyOncology's special issue focused on advancements in pediatric cancer treatment. Submit your research here: bit.ly/4l1xI5y #ASGCT #cancerresearch
Less than one month to submit your abstracts for #ASGCTAdvancing2025! We want to see your research - submit your work here today: asgct.org/events/2025-ad… See you in #Philly October 15-16!
🙌 @ESmithMDPhD, of @DanaFarber, has received the Outstanding New Investigator Award from The American Society of Gene + Cell Therapy, which recognizes achievements in the field of gene and cell therapies and cellular engineering. @ASGCTherapy 📚 buff.ly/c37FWUK
The first STPF Live Chat is ready to watch on-demand! Tips from fellows @JWSallmen and @AdrianaBankston: be involved in organizations that support your #scipol interests and think broadly about your discipline. Watch the recording here: bit.ly/4nDxIum
Discover how #India is revolutionizing #cancertreatment through innovative cell and gene therapy approaches at this free, live event. Join us July 9 for Around the World: #Oncology, #Hematology, and Cancer-Focused Cell and Gene Therapy in India! bit.ly/4kpJHZE #asgct
🧬 ASGCT Policy Summit | Sept 25-26, 2025 | DC Leading CGT experts tackle regulatory frameworks, AI in genetic medicine, and international harmonization. ASGCT members save $200+ Not a member? Join now + extend membership through Dec 2026 Register: asgct.org/policysummit
🎤 "The stakes are just so different here...this kid's life depends on whether this experiment worked." On our first episode of Soundbites of #ASGCT2025, @kiranmusunuru talks about Baby KJ and the story of his customized #CRISPR #geneediting therapy. bit.ly/43OaLg9
📢 Calling all ASGCT members: Apply for up to nearly $2 million in funded awards through Aug. 1! If you're a researcher growing your career, we invite you to learn more about our Career Development Award and our Underrepresented Populations Fellowship. bit.ly/3TgH54U
Thank you @FDA, Vinayak Prasad MD, & @DrMakaryFDA for convening a thoughtful #CGT roundtable today. ASGCT leaders Terry Flotte MD & @PaulaUSC MD joined peers in this future-forward discussion. Watch at 13:07 & 1:07:25: bit.ly/4mOP1Ig #GeneTherapy #CellTherapy #MedTwitter
Saturday’s final sessions: advances in #AAV, #oncolyticviruses, and new cell sources for untreatable conditions. Thank you for an inspiring week! #ASGCT2025
Navigating global regulatory requirements for #CGT development? Join our "Global Convergence: CMC Harmonization" symposium at #ASGCT2025, featuring experts from @Takeda and @BristolMyerSquibb who will share real-world strategies! May 16, 1:30-3:15 pm #ASGCTadvocacy
Don't miss today's Outstanding New Investigator Symposium at #ASGCT2025! Rising stars in genetic medicine present breakthrough research spanning rare metabolic disorders, CAR T-cell innovations, and vector engineering advances. 10:15 AM - NOON, Hall F. #CGTInnovation
Last chance to explore the #ASGCT2025 Exhibit Hall (until 3:45 PM), our New Member Meet-Up (1-1:30 pm, Booth 837), & Career Fair (3:15-4:15 PM, Level 200 Foyer). Don’t miss out!
Incredible story that we learned about today at #ASGCT2025!
CHOP & @PennMedicine have delivered the first-ever personalized gene editing therapy for a patient with CPS1 deficiency, marking a major milestone in the application of CRISPR-based treatments. Learn more about KJ & the future of personalized medicine: ms.spr.ly/6015SZLAx.
How is FDA's START Pilot Program accelerating #CGT development? Join our symposium at #ASGCT2025 from 3:45-5:30 pm to hear directly from participating companies! @NeurogeneInc, @ModernaTx, and @MyrtelleInc share their experiences with this innovative initiative. #ASGCTadvocacy
How can we advance cell & gene therapies in low- to middle-income countries? The #ASGCT2025 Challenges and Opportunities for CGTs in LMICs session tackles manufacturing, regulation, trial access & highlights global collaborative solutions. May 15, 8-9:45 am #ASGCTAdvocacy
Join us at #ASGCT2025 today from 8:00–9:45 AM in Room 393-396 for a Fireside Chat on funding the future of cell & gene therapy! Hear leaders from ARPA-H, NIH, CIRM & more discuss new funding models, public/private investment, and what’s next for CGT innovation.
What happens when promising CGT programs are deprioritized? Join our #ASGCT2025 fireside chat featuring Dr. Donald Kohn (@UCLA), Rachel McMinn (@NeurogeneInc), and other experts as they explore challenges and potential pathways forward for these therapies. #ASGCTadvocacy
ASGCT's Presidential Symposium begins today (10:15AM-12PM, Hall F). Join Drs. Paula Cannon and Terence Flotte as they chair presentations on breakthrough CGT approaches spanning mRNA therapeutics, HIV interventions, CRISPR, prion disease, and lentiviral vectors. #ASGCT2025
